rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-3-19
|
pubmed:abstractText |
Peginterferon alfa-2a plus ribavirin improves sustained virological responses compared with interferon alfa-2b and ribavirin, or peginterferon alfa-2a alone in chronic hepatitis C. We examined the impact of these treatments on health related quality of life (HRQOL).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0168-8278
|
pubmed:author |
pubmed-author:CooksleyGrahamG,
pubmed-author:GreenJesseJ,
pubmed-author:HassaneinTarekT,
pubmed-author:Horta E ValeAnaA,
pubmed-author:LaiMing-YangMY,
pubmed-author:MarinosGeorgeG,
pubmed-author:PastoreGiuseppeG,
pubmed-author:SmithColemanC,
pubmed-author:SulkowskiMarkM,
pubmed-author:Trejo-EstradaRafaelR,
pubmed-author:WintfeldNeilN
|
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
675-81
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15030985-Adult,
pubmed-meshheading:15030985-Antiviral Agents,
pubmed-meshheading:15030985-Drug Therapy, Combination,
pubmed-meshheading:15030985-Fatigue,
pubmed-meshheading:15030985-Female,
pubmed-meshheading:15030985-Hepatitis C, Chronic,
pubmed-meshheading:15030985-Humans,
pubmed-meshheading:15030985-Interferon-alpha,
pubmed-meshheading:15030985-Male,
pubmed-meshheading:15030985-Middle Aged,
pubmed-meshheading:15030985-Polyethylene Glycols,
pubmed-meshheading:15030985-Quality of Life,
pubmed-meshheading:15030985-Recombinant Proteins,
pubmed-meshheading:15030985-Ribavirin
|
pubmed:year |
2004
|
pubmed:articleTitle |
The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.
|
pubmed:affiliation |
Department of Medicine, Division of Gastroenterology and Hepatology, University of California, San Diego, USA. thassanein@ucsd.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|